首页> 美国卫生研究院文献>BMC Bioinformatics >A learning-based method for drug-target interaction prediction based on feature representation learning and deep neural network
【2h】

A learning-based method for drug-target interaction prediction based on feature representation learning and deep neural network

机译:基于特征表示学习和深神经网络的药物目标交互预测的基于学习方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Drug targets are special molecules that can bind to drugs and produce effects in cells, the main molecular targets for drugs are proteins [1]. Drug-target interactions (DTIs) prediction is of great significance for drug repositioning [2], drug discovery [3], side-effect prediction [4] and drug resistance [5]. However, identifying the drug-target interactions via biochemical and chemical biological experiments is costly and time-consuming [6]. Recently, as genomic, chemical, and pharmacological data become more and more complete, new opportunities for identifying drug target interactions have been emerged [2]. Therefore, many researchers have attempted to predict DTIs by using silico or computational approaches to guide in vivo validation in recent years, and thus significantly reduce the cost and time for identifying the drug-target interactions [2].
机译:药物靶标是可以与药物结合的特殊分子,并在细胞中产生效果,药物的主要分子靶标是蛋白质[1]。药物靶相互作用(DTI)预测对于药物重新定位的重要意义[2],药物发现[3],副作用预测[4]和耐药性[5]。然而,通过生化和化学生物实验鉴定药物靶标相互作用是昂贵且耗时的[6]。最近,作为基因组,化学和药理学数据变得越来越完整,已经出现了识别药物目标相互作用的新机会[2]。因此,许多研究人员已经尝试通过使用近年来使用硅或计算方法来预测DTI,从而预测近年来的体内验证,因此显着降低了识别药物靶标相互作用的成本和时间[2]。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号